BioWorld Asia

Aug. 13, 2003

Pyrosequencing Merging With Swedish Firm Personal Chemistry

Pyrosequencing AB, a Swedish sequencing instrumentation specialist, is buying its neighbor, Personal Chemistry i Uppsala AB, in a stock-based transaction valued at approximately SEK185.6 million (US$22.8 million). (BioWorld International) Read More

Alizyme Enters $42M Deal With Takeda, Its First Collaboration

International Team Shows How Epstein-Barr Virus Causes Cancer

Axovan To Move Clazosentan Into Phase III Early Next Year

Institutions Step In To Help CeNeS Out Of Elan Alliance

NeuroSearch Looking To Cash In With One Broad Pharma Alliance

Upcoming EU Rules On Clinical Trials Causing Concern In UK

Other News To Note

Today's news in brief

BioWorld

BioWorld briefs for Jan. 13, 2025.

Today's news in brief

BioWorld MedTech

BioWorld MedTech briefs for January 13, 2025

Caplyta star shines as J&J takes Intra-Cellular in $14.6B deal

BioWorld

The J.P. Morgan (JPM) Healthcare Conference in San Francisco kicked off with a resounding bang as Johnson & Johnson (J&J) disclosed plans to acquire...

Proteomics study explores how protein changes influence disease

BioWorld Science

Fourteen global pharma companies are getting together to conduct the largest proteomics study to date, analyzing 600,000 blood samples held in the UK Biobank to...

Type 1 diabetes breakthrough? Sana threads key ‘islet,’ SC-451 to advance

BioWorld

Sana Biotechnology Inc. CEO Steve Harr said “cool and transformative science” led to his firm’s latest strides in type 1 diabetes, and the “very generalizable...